BioNexus Gene Lab Corp (BGLC) Ownership
BGLC ownership summary
as of October 18, 2026- Institutions
- 0.5% of shares outstanding
- Insiders
- 44.72% of shares outstanding
- Shares outstanding
- 2.9M
- Float
- 1.7M shares available to trade
- Short interest
- 0.40% 10K shares short
- Days to cover
- 1.98 short interest down 22.4% vs prior month
- Institutions 0.49%
- Insiders 44.72%
- Other investors 54.79%
BGLC top institutional holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | HRT FINANCIAL LLC | 0.49% | 14K | $17,155 | +14,283 (0.0%) | June 30, 2026 |
| 2 | UBS Group AG | <0.01% | 101 | $121 | −130 (−56.3%) | June 30, 2026 |
| 3 | Caitong International Asset Management Co., Limited. | 0.00% | 1 | $1 | +1 (0.0%) | June 30, 2026 |
| 4 | DRW Securities, LLC | 0.00% | — | — | −47,830 (−100.0%) | March 31, 2026 |
| 5 | Wells Fargo & Co | 0.00% | — | — | −1 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 5, 2 holders added 14K shares and 3 cut 48K.
BGLC top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 0.10% | 2,368 | $2,844 | — | May 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
BGLC shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns BGLC
Institutional investors own 0.5% of BioNexus Gene Lab's shares and insiders 44.72%. The largest holder is HRT FINANCIAL LLC with 0.49% of the shares (14K), as of June 30, 2026. Among the top 5 institutions, 2 added shares and 3 reduced their stake in the latest filings. Short interest is 0.40% of the float, or 1.98 days of average trading volume. The share count rose 444.3% since 2017.
Related: BGLC key metrics. See the BGLC stock overview for the latest quote and news.
BGLC ownership FAQ
Who owns the most BioNexus Gene Lab stock?
The largest shareholders of BioNexus Gene Lab are HRT FINANCIAL LLC (0.49%), UBS Group AG (<0.01%), Caitong International Asset Management Co., Limited. (0.00%), DRW Securities, LLC (0.00%), Wells Fargo & Co (0.00%).
What percentage of BioNexus Gene Lab is owned by institutions?
Institutions hold 0.5% of BioNexus Gene Lab's shares outstanding; insiders hold 44.72%.
Which funds own BioNexus Gene Lab?
The largest fund holders of BioNexus Gene Lab are Fidelity Nasdaq Composite Index (0.10%).
What is BioNexus Gene Lab's short interest?
10K shares of BioNexus Gene Lab were sold short, 0.40% of the float; at the average daily volume it would take 1.98 days to cover.
How many shares of BioNexus Gene Lab are outstanding?
BioNexus Gene Lab has 2.9M shares outstanding, of which 1.7M are in the public float.